| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882812 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 7 Pages |
Abstract
This risk-adapted combined approach of selecting conditioning intensity and integrating post-transplant therapies results in lower non-relapse-mortality and encouraging improvement in survival. Our findings warrant confirmation in a large prospective multicenter trial.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Jean El Cheikh, Zaher K. Otrock, Abd Assalam Qannus, Mohamed A. Kharfan-Dabaja, Ali Bazarbachi,